These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10621552)

  • 1. New insights into pathogenesis and potential therapeutic options for Graves orbitopathy.
    Warwar RE
    Curr Opin Ophthalmol; 1999 Oct; 10(5):358-61. PubMed ID: 10621552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graves' ophthalmopathy. A clinical and immunologic review.
    Sergott RC; Glaser JS
    Surv Ophthalmol; 1981; 26(1):1-21. PubMed ID: 6895125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graves ophthalmopathy.
    Bradley EA
    Curr Opin Ophthalmol; 2001 Oct; 12(5):347-51. PubMed ID: 11588496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.
    Schlüter A; Horstmann M; Diaz-Cano S; Plöhn S; Stähr K; Mattheis S; Oeverhaus M; Lang S; Flögel U; Berchner-Pfannschmidt U; Eckstein A; Banga JP
    Clin Exp Immunol; 2018 Mar; 191(3):255-267. PubMed ID: 29058307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graves' ophthalmopathy.
    Wall JR; Henderson J; Strakosch CR; Joyner DM
    Can Med Assoc J; 1981 Apr; 124(7):855-62, 866. PubMed ID: 7011529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
    Salvi M; Bingoye F; Chung F; Wall JR
    J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves' ophthalmopathy.
    Bahn RS
    J Endocrinol Invest; 2004 Mar; 27(3):216-20. PubMed ID: 15164996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Graves' orbitopathy].
    Balázs C
    Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders.
    Kuroki T; Ruf J; Whelan L; Miller A; Wall JR
    Clin Exp Immunol; 1985 Nov; 62(2):361-70. PubMed ID: 3841305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines in the evolution of Graves' ophthalmopathy.
    Natt N; Bahn RS
    Autoimmunity; 1997; 26(2):129-36. PubMed ID: 9546815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graves' ophthalmopathy: state of the art and perspectives.
    Bartalena L; Wiersinga WM; Pinchera A
    J Endocrinol Invest; 2004 Mar; 27(3):295-301. PubMed ID: 15165007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The putative role of prostaglandin endoperoxide H synthase-2 in the pathogenesis of thyroid-associated orbitopathy.
    Smith TJ
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 5():S160-3. PubMed ID: 10614912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current insights into animal models of Graves' disease and orbitopathy.
    Wiesweg B; Johnson KT; Eckstein AK; Berchner-Pfannschmidt U
    Horm Metab Res; 2013 Aug; 45(8):549-55. PubMed ID: 23613015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graves' ophthalmopathy and atrophic thyroiditis: a case report.
    Tamagno G; De Carlo E; Betterle C; Murialdo G
    J Endocrinol Invest; 2004 Feb; 27(2):163-6. PubMed ID: 15129812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orbital fibroblasts exhibit a novel pattern of responses to proinflammatory cytokines: potential basis for the pathogenesis of thyroid-associated ophthalmopathy.
    Smith TJ
    Thyroid; 2002 Mar; 12(3):197-203. PubMed ID: 11952039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenesis of Graves' ophthalmopathy].
    Heufelder AE
    Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():35-9. PubMed ID: 10355048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graves' ophthalmopathy.
    Yeatts RP
    Med Clin North Am; 1995 Jan; 79(1):195-209. PubMed ID: 7808092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current understanding of pathogenesis of Graves ophthalmopathy].
    Ando T; Eguchi K
    Nihon Rinsho; 2006 Dec; 64(12):2275-8. PubMed ID: 17154091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graves' ophthalmopathy.
    Bistriceanu M; Cergă A; Lichiardopol-Răducanu C
    Oftalmologia; 1993; 37(2):99-103. PubMed ID: 8507632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of thyroid ophthalmopathy.
    Kraus DJ
    Curr Opin Ophthalmol; 1996 Oct; 7(5):54-9. PubMed ID: 10165108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.